Building on the momentum of the Poland Country Profile and Denmark Country Profile, the Rethinking Schizophrenia initiative now turns its focus to Germany, examining how national policy can support more integrated, person-centred schizophrenia care. The Germany Country Profile builds on discussions from a Germany-focused webinar held on 4 March 2026, organised by the European [...]
The European Brain Council (EBC) warmly welcomes the publication of the S7 Academies Joint Statement “Advancing Brain Health (including Mental Health) for Global Societal Resilience”, delivered in the framework of the G7 process and calling for brain health to become a cross-cutting global policy priority. Signed by leading scientific academies from Canada, France, Germany, [...]
Neurotechnology touches some of the most intimate dimensions of being human – cognition, behaviour, mental health, autonomy, identity. From brain implants restoring movement to consumer devices marketed for sleep and focus, it is reshaping healthcare and raising profound ethical questions at the same time. Europe is already the world’s second-largest neurotechnology market. But despite [...]
The European Brain Council is pleased to introduce the Seal of Responsible Neurotechnology, a voluntary ethical label to address unmet governance needs in the neurotechnology sector.Neurotechnology, encompassing devices and procedures that interact with the brain and nervous system, are increasingly deployed outside clinical settings, raising ethical questions about human agency, mental privacy and freedom of [...]
EBC at the 34th European Congress of Psychiatry The European Brain Council (EBC) was proud to participate in the 34th European Congress of Psychiatry, organised by the European Psychiatric Association (EPA) and held at the Prague Congress Centre from 28 to 31 March 2026. Gathering thousands of mental health [...]
Introduction Following the recommendations set out in the Rethinking Schizophrenia Care Pathway in Europe study paper, the next phase of the project — Country Profiles: Beyond Mental Health – A Brain Health Approach to Schizophrenia Prevention and Care — focuses on analysing country-specific models of care and identifying opportunities to improve prevention, early detection and integrated care across Europe. After a roundtable [...]
On 18 March 2026, policymakers, researchers, clinicians, patient representatives and industry leaders gathered in Brussels for Brain Health Day: Prevention, Policy, Progress - a full day of activities organised by the Brain Health Mission, the European Academy of Neurology with the European Brain Council and the Federation of European Neuroscience Societies. Taking place during [...]
The European Brain Council (EBC) welcomes the first part of the EU Biotech Act as proposed by the European Commission. It is indeed regarded as timely initiative to strengthen Europe’s capacity to translate its excellence in science into tangible health solutions. In particular, its aims to strengthen the EU’s biotechnology and biomanufacturing ecosystem, with an initial and explicit focus on health biotechnology, [...]
The European Brain Council (EBC) Rare Disease Day Event convened clinicians, patients, policymakers, researchers and industry leaders to advance coordination on rare diseases in Europe. Building on the Rare Brain Disease (RBD) Ecosystem, the event sought to identify systemic gaps, strengthen research–care integration, and review EU regulatory and research developments. A key outcome was [...]
On 24 February 2026, the European Parliament Committee on Public Health (SANT) held a Public Hearing on ‘Brain health: Policy challenges and opportunities to manage neurological diseases’. The European Brain Council (EBC) was pleased to be invited to take part in this essential discussion through the contribution of its President-Elect, Professor Sameer Zuberi, as [...]
